Your browser doesn't support javascript.
loading
Characterization of Reference Materials with an Association for Molecular Pathology Pharmacogenetics Working Group Tier 2 Status: CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, and GGCX: A GeT-RM Collaborative Project.
Pratt, Victoria M; Turner, Amy; Broeckel, Ulrich; Dawson, D Brian; Gaedigk, Andrea; Lynnes, Ty C; Medeiros, Elizabeth B; Moyer, Ann M; Requesens, Deborah; Vetrini, Francesco; Kalman, Lisa V.
Affiliation
  • Pratt VM; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana.
  • Turner A; RPRD Diagnostics, Milwaukee, Wisconsin; Department of Pediatrics, Section on Genomic Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Broeckel U; RPRD Diagnostics, Milwaukee, Wisconsin; Department of Pediatrics, Section on Genomic Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Dawson DB; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio; Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Gaedigk A; Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Children's Mercy Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri.
  • Lynnes TC; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana.
  • Medeiros EB; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana.
  • Moyer AM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Requesens D; Coriell Institute for Medical Research, Camden, New Jersey.
  • Vetrini F; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana.
  • Kalman LV; Division of Laboratory Systems, Centers for Disease Control and Prevention, Atlanta, Georgia. Electronic address: LJK0@cdc.gov.
J Mol Diagn ; 23(8): 952-958, 2021 08.
Article in En | MEDLINE | ID: mdl-34020041
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacogenetics / Carboxy-Lyases / Cytochrome P-450 Enzyme System / Vitamin K Epoxide Reductases / Cytochrome P-450 CYP2C9 / Cytochrome P-450 CYP2C19 / Pharmacogenomic Variants Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Mol Diagn Journal subject: BIOLOGIA MOLECULAR Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacogenetics / Carboxy-Lyases / Cytochrome P-450 Enzyme System / Vitamin K Epoxide Reductases / Cytochrome P-450 CYP2C9 / Cytochrome P-450 CYP2C19 / Pharmacogenomic Variants Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Mol Diagn Journal subject: BIOLOGIA MOLECULAR Year: 2021 Document type: Article